000			02096 a2200589 4500
005			20250515104945.0
264		0	_c20080908
008			200809s 0 0 eng d
022			_a0008-6363
024	7		_a10.1093/cvr/cvn017 _2doi
040			_aNLM _beng _cNLM
100	1		_aGonon, Adrian T
245	0	0	_aAdiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide. _h[electronic resource]
260			_bCardiovascular research _cApr 2008
300			_a116-22 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAMP-Activated Protein Kinases
650	0	4	_aAdiponectin _xmetabolism
650	0	4	_aAnimals
650	0	4	_aBlotting, Western
650	0	4	_aCoronary Circulation
650	0	4	_aDisease Models, Animal
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aHemodynamics
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMultienzyme Complexes _xmetabolism
650	0	4	_aMyocardial Contraction
650	0	4	_aMyocardial Infarction _xenzymology
650	0	4	_aMyocardial Reperfusion Injury _xenzymology
650	0	4	_aMyocardium _xenzymology
650	0	4	_aNitric Oxide _xmetabolism
650	0	4	_aNitric Oxide Synthase Type II _xantagonists & inhibitors
650	0	4	_aNitric Oxide Synthase Type III
650	0	4	_aNitroarginine _xpharmacology
650	0	4	_aPhosphorylation
650	0	4	_aProtein Serine-Threonine Kinases _xmetabolism
650	0	4	_aProto-Oncogene Proteins c-akt _xmetabolism
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTime Factors
650	0	4	_aVentricular Function, Left
700	1		_aWidegren, Ulrika
700	1		_aBulhak, Aliaksandr
700	1		_aSalehzadeh, Firoozeh
700	1		_aPersson, Jonas
700	1		_aSjöquist, Per-Ove
700	1		_aPernow, John
773	0		_tCardiovascular research _gvol. 78 _gno. 1 _gp. 116-22
856	4	0	_uhttps://doi.org/10.1093/cvr/cvn017 _zAvailable from publisher's website
999			_c17730130 _d17730130